Target intelligence / Profile preview

RNA, U6 small nuclear 282, pseudogene (RNU6-282P)

Target
RNU6-282P
Molecular classification
Other (specifically, pseudogene), Small nuclear RNA gene family (snRNA pseudogene)
01

Overview

RNU6-282P is a pseudogene related to the U6 small nuclear RNA gene. U6 snRNA is a highly conserved, functional component of the spliceosome that is essential for pre-mRNA splicing in eukaryotes. However, pseudogenes like RNU6-282P are non-functional genomic copies that are not transcribed into active RNA and do not participate in biological processes such as splicing. The human genome contains many U6 pseudogenes[3][5], and these are generally considered evolutionary remnants rather than active players in cell biology. Their identification and annotation are important in genomics but have no direct relevance for therapy, mechanism-of-action studies, or biomarker development. If you are seeking functional information relevant to therapy, drug interaction, or molecular targeting, it would be more appropriate to focus on U6 small nuclear RNA (U6 snRNA), not its pseudogene variants[1][3].

Other names
RNU6-282PU6 small nuclear RNA pseudogene 282U6 pseudogene
02

Mechanism of action

None (no mechanisms, as it is not a functional molecule)

03

Biological functions

None (as a pseudogene, RNU6-282P does not have an active biological function)
04

Disease associations

None (pseudogenes like RNU6-282P are typically not implicated in disease; functional U6 snRNA may be important in spliceosomal activity, but the pseudogene version is not)
05

Safety considerations

None (pseudogene sequences do not pose direct safety or therapeutic challenges)
06

Interacting drugs

None (no drugs directly interact with this pseudogene)
07

Biomarkers

None (not used as a biomarker)

Beyond the preview

Go deeper on RNA, U6 small nuclear 282, pseudogene (RNU6-282P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 282, pseudogene (RNU6-282P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call